Clinical Trial Update: Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating a cell-culture derived Emulsion HA vaccine for Swine-origin Influenza A H1N1 virus infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine-origin Influenza H1n1 Virus Infection

Drugs mentioned

• Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Swine-Origin Influenza A H1N1 Virus | Status: COMPLETED